Article

Both Parties See Gains Coming From Medicare Debate

A little more than two weeks before Election Day, Republicans and Democrats alike say Medicare is working to their political advantage in campaigns for the White House and Congress.

They can't both be right, and no matter which side is, this is one campaign clash with consequences extending well beyond Nov. 6.

Read the full story: http://yhoo.it/TzAE5m

Source: The Associated Press

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Addressing Cost Barriers to Medication Adherence: Sam Peasah, PhD
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Biosimilar Adoption, Legislative Action With PBMs: JC Scott
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Investigators Advocate for Ongoing Comparison of Cancer Outcomes Among MA, FFS Beneficiaries
Galen Shearn-Nance, BS
No Significant Differences Found in Breast Cancer Treatment Between MA, FFS Beneficiaries: Galen Shearn-Nance, BS
Dr Johnie Rose
Mixed Outcomes Persist Between MA, FFS Beneficiaries: Johnie Rose, MD, PhD
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Legislative Updates Shaping Managed Care Pharmacy: Adam Colborn, JD
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
A Pharmacist's Role in Selecting Effective, Affordable Breast Cancer Therapies
Dr Andrew S. Oseran
Further Research Into Medicare Advantage Upcoding, Documentation Accuracy Needed
o Richard Hughes IV, JD, MPH, Epstein Becker Green
Payer Responsibility for Preventive Services May Hinge on Braidwood Decision
Dr Andrew S. Oseran
Chronic Condition Prevalence Similar in Medicare Advantage, Traditional Medicare Beneficiaries
Related Content
glp-1 Wegovy, semaglutide | Image credit: Patrick Bay Damsted - stock.adobe.com
April 25th 2025

Can Medicare Sustain Widespread Access to GLP-1 Therapies?

Skylar Jeremias
Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.
managed care cast logo
April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD
On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Richard Hughes IV, JD, MPH
April 21st 2025

What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV

Julia Bonavitacola Richard Hughes IV, JD, MPH
Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Seniors receiving health care | Image credit: Adobe.com
April 11th 2025

Sutter Health, SCAN Announce Partnership to Launch New MA Products, Joint Venture Health Plan

Mary Caffrey
The California-based entities plan to offer new Medicare Advantage (MA) products in select counties by this fall.
"Medicare Advantage" written on notepad | Image Credit: dizain - stock.adobe.com
April 7th 2025

Differential Coding Inflated Medicare Advantage Payments by $33 Billion in 2021, Study Finds

Brooke McCormick
In 2021, UnitedHealth Group received 42% of the $33 billion in additional Medicare Advantage payments from differential coding.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo